Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.
Salcedo M, Prieto M, Castells L, Pascasio JM, Montero Alvarez JL, Fernández I, Sánchez-Antolín G, González-Diéguez L, García-Gonzalez M, Otero A, Lorente S, Espinosa MD, Testillano M, González A, Castellote J, Casafont F, Londoño MC, Pons JA, Molina Pérez E, Cuervas-Mons V, Pascual S, Herrero JI, Narváez I, Vinaixa C, Llaneras J, Sousa JM, Bañares R. Salcedo M, et al. Among authors: espinosa md. Transpl Int. 2017 Oct;30(10):1041-1050. doi: 10.1111/tri.12999. Epub 2017 Jul 27. Transpl Int. 2017. PMID: 28608619 Free article.
Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.
Cuervas-Mons V, Herrero JI, Gomez MA, González-Pinto I, Serrano T, de la Mata M, Fabregat J, Gastaca M, Bilbao I, Varo E, Sánchez-Antolín G, Rodrigo J, Espinosa MD. Cuervas-Mons V, et al. Among authors: espinosa md. Clin Transplant. 2015 Aug;29(8):667-77. doi: 10.1111/ctr.12557. Epub 2015 Jun 29. Clin Transplant. 2015. PMID: 25924549 Clinical Trial.
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort.
Pérez AB, Chueca N, Macías J, Pineda JA, Salmerón J, Rivero-Juárez A, Hidalgo-Tenorio C, Espinosa MD, Téllez F, Von-Wichmann MÁ, Omar M, Santos J, Hernández-Quero J, Antón JJ, Collado A, Lozano AB, García-Deltoro M, Casado M, Pascasio JM, Selfa A, Rosales JM, De la Iglesia A, Arenas JI, García-Bujalance S, Ríos MJ, Bernal E, Martínez O, García-Herola A, Vélez M, Rincón P, García F. Pérez AB, et al. Among authors: espinosa md. PLoS One. 2019 Aug 30;14(8):e0221231. doi: 10.1371/journal.pone.0221231. eCollection 2019. PLoS One. 2019. PMID: 31469856 Free PMC article.
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.
Pérez AB, Chueca N, García-Deltoro M, Martínez-Sapiña AM, Lara-Pérez MM, García-Bujalance S, Aldámiz-Echevarría T, Vera-Méndez FJ, Pineda JA, Casado M, Pascasio JM, Salmerón J, Alados-Arboledas JC, Poyato A, Téllez F, Rivero-Juárez A, Merino D, Vivancos-Gallego MJ, Rosales-Zábal JM, García F; GEHEP-004 Study Group. Pérez AB, et al. J Hepatol. 2019 Nov;71(5):876-888. doi: 10.1016/j.jhep.2019.06.022. Epub 2019 Jul 4. J Hepatol. 2019. PMID: 31279901
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.
Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels.
Calleja JL, García-Samaniego J, Ruiz-Antorán B, Trapero M, Morillas R, de la Revilla J, Erdozaín JC, Espinosa MD, Suárez D, Solá R, Romero-Gómez M, Baños F, Alvarez MA; Management of HCV Infection and Normal Transaminases Spanish Study Group. Calleja JL, et al. Among authors: espinosa md. J Gastroenterol Hepatol. 2012 Nov;27(11):1705-10. doi: 10.1111/j.1440-1746.2012.07214.x. J Gastroenterol Hepatol. 2012. PMID: 22742958
Influence of aortic regurgitation after TAVI on left ventricular filling pattern.
Caballero L, Saura D, García-Lara J, Oliva MJ, Pinar E, González-Carrillo J, García-Navarro M, Espinosa MD, Valdés M, de la Morena G. Caballero L, et al. Among authors: espinosa md. Eur J Clin Invest. 2015 Jan;45(1):18-26. doi: 10.1111/eci.12374. Eur J Clin Invest. 2015. PMID: 25402558
Severe aortic valve stenosis with low-gradient and preserved ejection fraction: a misclassification issue?
González-Cánovas C, Muñoz-Esparza C, Oliva MJ, González-Carrillo J, López-Cuenca Á, Saura D, García-Navarro M, Espinosa MD, Caro C, Caballero L, Valdés M, de la Morena G. González-Cánovas C, et al. Among authors: espinosa md. Rev Esp Cardiol (Engl Ed). 2013 Apr;66(4):255-60. doi: 10.1016/j.rec.2012.08.010. Epub 2012 Dec 8. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24775614
Aortic valve stenosis planimetry by means of three-dimensional transesophageal echocardiography in the real clinical setting: feasibility, reliability and systematic deviations.
Saura D, de la Morena G, Flores-Blanco PJ, Oliva MJ, Caballero L, González-Carrillo J, Espinosa MD, López-Ruiz M, García-Navarro M, Valdés M. Saura D, et al. Among authors: espinosa md. Echocardiography. 2015 Mar;32(3):508-15. doi: 10.1111/echo.12675. Epub 2014 Jul 5. Echocardiography. 2015. PMID: 25041359
35 results